Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species

[1]  B. '. ’t Hart,et al.  Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis , 2013, The Journal of Immunology.

[2]  A. Lutterotti,et al.  Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders , 2011, Journal of Neuroinflammation.

[3]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[4]  K. Mills,et al.  TLR-dependent T cell activation in autoimmunity , 2011, Nature Reviews Immunology.

[5]  K. Berer,et al.  B cells in spontaneous autoimmune diseases of the central nervous system. , 2011, Molecular immunology.

[6]  A. Minagar.  Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis , 2011 .

[7]  J. Andersson,et al.  High content cellular immune profiling reveals differences between rhesus monkeys and men , 2010, Immunology.

[8]  S. Kaufmann,et al.  Infection, inflammation, and chronic diseases: consequences of a modern lifestyle. , 2010, Trends in immunology.

[9]  B. '. ’t Hart,et al.  Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56 Peptide in Incomplete Freund Adjuvant , 2010, Journal of neuropathology and experimental neurology.

[10]  Penghui Yang,et al.  Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys. , 2009, International immunopharmacology.

[11]  B. '. ’t Hart,et al.  Clinical, Pathological, and Immunologic Aspects of the Multiple Sclerosis Model in Common Marmosets (Callithrix jacchus) , 2009, Journal of neuropathology and experimental neurology.

[12]  G. Strijkers,et al.  Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34–56-Specific Cytotoxic T Cells1 , 2008, The Journal of Immunology.

[13]  C. Genain,et al.  Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid‐phase ELISA , 2007, European journal of immunology.

[14]  A. Ben-nun,et al.  The human CMV-UL86 peptide 981–1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34–56, but lacks the capacity to induce EAE in rhesus monkeys , 2007, Journal of Neuroimmunology.

[15]  D. Pham‐Dinh,et al.  Complex alternative splicing of the myelin oligodendrocyte glycoprotein gene is unique to human and non‐human primates , 2006, Journal of neurochemistry.

[16]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[17]  R. Ransohoff.  EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. , 2006, Trends in immunology.

[18]  D. Pham‐Dinh,et al.  Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Subramaniam Sriram,et al.  Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis , 2005, Annals of neurology.

[20]  S. Amor,et al.  Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme , 2005, Journal of Neuroimmunology.

[21]  B. Lambrecht,et al.  Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease , 2005, The Journal of Immunology.

[22]  P. Gasque,et al.  Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation , 2005 .

[23]  R. Hohlfeld,et al.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Hauser,et al.  Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination , 2004, European journal of immunology.

[25]  J. LaManna,et al.  The Third Signal in T Cell-Mediated Autoimmune Disease?1 , 2004, The Journal of Immunology.

[26]  B. '. ’t Hart,et al.  Evaluating the validity of animal models for research into therapies for immune-based disorders. , 2004, Drug discovery today.

[27]  B. '. ’t Hart,et al.  The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system. , 2003, Current opinion in neurology.

[28]  C. Pitcher,et al.  Development and Homeostasis of T Cell Memory in Rhesus Macaque1 , 2002, The Journal of Immunology.

[29]  A. Billiau,et al.  Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases , 2001, Journal of leukocyte biology.

[30]  K. Nam,et al.  Experimental autoimmune encephalomyelitis in cynomolgus monkeys. , 2000, Journal of veterinary science.

[31]  A. Ben-nun,et al.  Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes , 2000, Journal of Neuroimmunology.

[32]  K. Nicolay,et al.  Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule1 , 2000, The Journal of Immunology.

[33]  K. Nicolay,et al.  Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule , 2000 .

[34]  N. Wolf,et al.  Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. , 1999, Journal of immunology.

[35]  A. Ben-nun,et al.  Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions , 1997, European journal of immunology.

[36]  Tomas Olsson,et al.  Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant , 1995, Journal of Neuroimmunology.

[37]  R. Bontrop,et al.  Resistance to collagen‐induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen , 1993, European journal of immunology.

[38]  R. Bontrop,et al.  Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region , 1992, The Journal of experimental medicine.

[39]  B. '. ’t Hart,et al.  Collagen-induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen-specific immunity. , 1991, Arthritis and rheumatism.

[40]  T. Richards,et al.  Remitting-relapsing EAE in nonhuman primates: a valid model of multiple sclerosis. , 1991, Clinical immunology and immunopathology.

[41]  E. Alvord,et al.  Chronic remitting‐relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein , 1988, Annals of neurology.

[42]  E. Alvord,et al.  Fluctuations of T- and B-cell subsets in basic protein-induced experimental allergic encephalomyelitis (EAE) in long-tailed macaques. , 1987, Clinical immunology and immunopathology.